Cellectis CLLS
NASDAQ CLLS
$3.24 -0.08 (-2.41%)
At close: Sep 4, 2026 · 4:00 PM EDT

Cellectis (CLLS) Net Income (2015 - 2026)

Cellectis (CLLS) posted quarterly Net Income of -$17.8 million for Q1 2026, up 2.0% year-over-year from -$17.4 million in Q1 2025, and up 83.17% quarter-over-quarter from -$105.5 million in Q4 2025.

Analysis

Cellectis (CLLS) Net Income (2015 - 2026) Analysis & Trends

Cellectis' Net Income history runs 12 years deep, the most recent figure standing at -$17.8 million for Q1 2026.

  • In Q1 2026, Net Income rose 2.0% year-over-year to -$17.8 million; the TTM figure through Mar 2026 stood at -$85.2 million (down 65.09% YoY), while the FY2023 annual figure was $8.4 million, up 154.69% from the prior year.
  • Net Income for Q1 2026 stood at -$17.8 million, up from -$105.5 million in the prior quarter.
  • The five-year high for Net Income was $59.8 million in Q2 2022, with the low at -$105.5 million in Q4 2025.
  • The 5-year median for Net Income is -$4.7 million (2023), against an average of -$6.4 million.
  • The sharpest annual moves came in 2022 and 2025: Net Income surged 265.42% in 2022, then slumped 156.49% in 2025.
  • Cellectis' Net Income stood at -$2.9 million in 2022, then jumped by 557.93% to $13.1 million in 2023, then sank by 414.52% to -$41.1 million in 2024, then tumbled by 156.49% to -$105.5 million in 2025, then soared by 83.17% to -$17.8 million in 2026.
  • Business Quant data shows CLLS's Net Income at -$17.8 million in Q1 2026, -$105.5 million in Q4 2025, and $22.4 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 1.10 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 1.30 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 601.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -782.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -644.37 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 237.01 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 164.49 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 81.49 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -13.27 Mn
10 Cellectis 321.90 Mn 155.05 Mn - -21.82 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -21.82 Mn
Mar 31, 2026 -17.77 Mn
Dec 31, 2025 -3.42 Mn
Sep 30, 2025 22.41 Mn
Jun 30, 2025 -23.74 Mn
Mar 31, 2025 -18.13 Mn
Dec 31, 2024 -37.78 Mn
Sep 30, 2024 2.86 Mn
Jun 30, 2024 -25.31 Mn
Mar 31, 2024 11.39 Mn
Dec 31, 2023 -118.06 Mn
Sep 30, 2023 -546,000.00
Jun 30, 2023 17.56 Mn
Mar 31, 2023 -26.57 Mn
Dec 31, 2022 -5.61 Mn
Sep 30, 2022 -29.09 Mn
Jun 30, 2022 -19.45 Mn
Mar 31, 2022 -5.62 Mn
Dec 31, 2021 222.13 Mn
Sep 30, 2021 -42.37 Mn